• Don't miss the opportunity to attend Tinnitus Quest's online Q&A with Dr. Susan Shore and Jon Pearson, CEO of Auricle on October 13. We will hear the latest about the Susan Shore Device.

    ➡️ Details & Registration!

Tinnitus Talk Support Forum

S
Other than that, Flexion therapeutics' FX301 is a drug to look out for, set to initiate Phase 1b soon (Flexion acquired the rights to develop Xenon's XEN402)